These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 33864233)

  • 41. Mesenchymal stem cells neither fully acquire the electrophysiological properties of mature cardiomyocytes nor promote ventricular arrhythmias in infarcted rats.
    Wei F; Wang TZ; Zhang J; Yuan ZY; Tian HY; Ni YJ; Zhuo XZ; Han K; Liu Y; Lu Q; Bai HY; Ma AQ
    Basic Res Cardiol; 2012 Jul; 107(4):274. PubMed ID: 22744762
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MicroRNA-338 in MSCs-derived exosomes inhibits cardiomyocyte apoptosis in myocardial infarction.
    Fu DL; Jiang H; Li CY; Gao T; Liu MR; Li HW
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):10107-10117. PubMed ID: 33090418
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epigenetic reprogramming converts human Wharton's jelly mesenchymal stem cells into functional cardiomyocytes by differential regulation of Wnt mediators.
    Bhuvanalakshmi G; Arfuso F; Kumar AP; Dharmarajan A; Warrier S
    Stem Cell Res Ther; 2017 Aug; 8(1):185. PubMed ID: 28807014
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chemical and physical stimuli induce cardiomyocyte differentiation from stem cells.
    Ge D; Liu X; Li L; Wu J; Tu Q; Shi Y; Chen H
    Biochem Biophys Res Commun; 2009 Apr; 381(3):317-21. PubMed ID: 19309791
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Concomitant Retrograde Coronary Venous Infusion of Basic Fibroblast Growth Factor Enhances Engraftment and Differentiation of Bone Marrow Mesenchymal Stem Cells for Cardiac Repair after Myocardial Infarction.
    Wang X; Zhen L; Miao H; Sun Q; Yang Y; Que B; Lopes Lao EP; Wu X; Ren H; Shi S; Lau WB; Ma X; Ma C; Nie S
    Theranostics; 2015; 5(9):995-1006. PubMed ID: 26155315
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fluorescent conjugated polymer nanovector for in vivo tracking and regulating the fate of stem cells for restoring infarcted myocardium.
    Jin G; Li W; Song F; Zhao J; Wang M; Liu Q; Li A; Huang G; Xu F
    Acta Biomater; 2020 Jun; 109():195-207. PubMed ID: 32294553
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mesenchymal Stem Cell Therapy for Patients with Ischemic Heart Failure- Past, Present, and Future.
    Liang P; Ye F; Hou CC; Pi L; Chen F
    Curr Stem Cell Res Ther; 2021; 16(5):608-621. PubMed ID: 32148201
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mesenchymal stem cells and their conditioned medium improve integration of purified induced pluripotent stem cell-derived cardiomyocyte clusters into myocardial tissue.
    Rubach M; Adelmann R; Haustein M; Drey F; Pfannkuche K; Xiao B; Koester A; Udink ten Cate FE; Choi YH; Neef K; Fatima A; Hannes T; Pillekamp F; Hescheler J; Šarić T; Brockmeier K; Khalil M
    Stem Cells Dev; 2014 Mar; 23(6):643-53. PubMed ID: 24219308
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mesenchymal stem cell transplantation improves regional cardiac remodeling following ovine infarction.
    Zhao Y; Li T; Wei X; Bianchi G; Hu J; Sanchez PG; Xu K; Zhang P; Pittenger MF; Wu ZJ; Griffith BP
    Stem Cells Transl Med; 2012 Sep; 1(9):685-95. PubMed ID: 23197875
    [TBL] [Abstract][Full Text] [Related]  

  • 50. miR-19a/19b-loaded exosomes in combination with mesenchymal stem cell transplantation in a preclinical model of myocardial infarction.
    Wang S; Li L; Liu T; Jiang W; Hu X
    Regen Med; 2020 Jun; 15(6):1749-1759. PubMed ID: 32772806
    [No Abstract]   [Full Text] [Related]  

  • 51. Guanxin Danshen Formulation improved the effect of mesenchymal stem cells transplantation for the treatment of myocardial infarction probably via enhancing the engraftment.
    Han XJ; Li H; Liu CB; Luo ZR; Wang QL; Mou FF; Guo HD
    Life Sci; 2019 Sep; 233():116740. PubMed ID: 31398416
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bone marrow-derived mesenchymal stromal cells express cardiac-specific markers, retain the stromal phenotype, and do not become functional cardiomyocytes in vitro.
    Rose RA; Jiang H; Wang X; Helke S; Tsoporis JN; Gong N; Keating SC; Parker TG; Backx PH; Keating A
    Stem Cells; 2008 Nov; 26(11):2884-92. PubMed ID: 18687994
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In Vitro Grown Micro-Tissues for Cardiac Cell Replacement Therapy in Vivo.
    Sahito RGA; Sheng X; Maass M; Mikhael N; Hamad S; Heras-Bautista CO; Derichsweiler D; Spitkovsky D; Suhr F; Khalil M; Brockmeier K; Halbach M; Saric T; Hescheler J; Krausgrill B; Pfannkuche K
    Cell Physiol Biochem; 2019; 52(6):1309-1324. PubMed ID: 31050280
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mesenchymal stem cells from fetal heart attenuate myocardial injury after infarction: an in vivo serial pinhole gated SPECT-CT study in rats.
    Garikipati VN; Jadhav S; Pal L; Prakash P; Dikshit M; Nityanand S
    PLoS One; 2014; 9(6):e100982. PubMed ID: 24971627
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Donor mesenchymal stromal cells (MSCs) undergo variable cardiac reprogramming in vivo and predominantly co-express cardiac and stromal determinants after experimental acute myocardial infarction.
    Yannarelli G; Tsoporis JN; Desjardins JF; Wang XH; Pourdjabbar A; Viswanathan S; Parker TG; Keating A
    Stem Cell Rev Rep; 2014 Apr; 10(2):304-15. PubMed ID: 24287730
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anti-oxidant activity reinforced reduced graphene oxide/alginate microgels: Mesenchymal stem cell encapsulation and regeneration of infarcted hearts.
    Choe G; Kim SW; Park J; Park J; Kim S; Kim YS; Ahn Y; Jung DW; Williams DR; Lee JY
    Biomaterials; 2019 Dec; 225():119513. PubMed ID: 31569016
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells Promote Fibroblast-to-Myofibroblast Differentiation in Inflammatory Environments and Benefit Cardioprotective Effects.
    Shi Y; Yang Y; Guo Q; Gao Q; Ding Y; Wang H; Xu W; Yu B; Wang M; Zhao Y; Zhu W
    Stem Cells Dev; 2019 Jun; 28(12):799-811. PubMed ID: 30896296
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Co-expression of Akt1 and Wnt11 promotes the proliferation and cardiac differentiation of mesenchymal stem cells and attenuates hypoxia/reoxygenation-induced cardiomyocyte apoptosis.
    Chen B; Chen X; Liu C; Li J; Liu F; Huang Y
    Biomed Pharmacother; 2018 Dec; 108():508-514. PubMed ID: 30243083
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vivo priming of human mesenchymal stem cells with hepatocyte growth factor-engineered mesenchymal stem cells promotes therapeutic potential for cardiac repair.
    Park BW; Jung SH; Das S; Lee SM; Park JH; Kim H; Hwang JW; Lee S; Kim HJ; Kim HY; Jung S; Cho DW; Jang J; Ban K; Park HJ
    Sci Adv; 2020 Mar; 6(13):eaay6994. PubMed ID: 32284967
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rapamycin-Preactivated Autophagy Enhances Survival and Differentiation of Mesenchymal Stem Cells After Transplantation into Infarcted Myocardium.
    Li ZH; Wang YL; Wang HJ; Wu JH; Tan YZ
    Stem Cell Rev Rep; 2020 Apr; 16(2):344-356. PubMed ID: 31927699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.